Events

Topic: Providing telehealth medication abortion care through an equity lens

 

Emily M. Godfrey, MD, MPH, FAAFP

Professor of Family Medicine and Obstetrics and Gynecology,

University of Washington

 

Anna Fiastro, MPH, MEM, PhD

Research Scientist,

Department of Family Medicine,

University of Washington

ABSTRACT

Induced abortion is one of the most commonly prescribed medical interventions in the United States, yet legislators have made it increasingly difficult to obtain. Following the June 2022 U.S. Supreme Court decision, Dobbs v. Jackson Women’s Health Organization, it is now estimated that more than 100,000 people annually will be barred from receiving an abortion in their respective home states. Lack of access disproportionately affects members of marginalized communities, people of color and persons of lower socioeconomic status, which will only further exacerbate our nation’s burgeoning maternal mortality public health crisis. UW’s Access, Delivered research team presents findings from research conducted before the Dobbs decision on new models of care for medication abortion services and individuals seeking these services compared to those seeking traditional in-clinic services. These findings give insights into how to address health disparities in light of the severe abortion restrictions that individuals now face in states throughout the U.S.

LEARNING OBJECTIVES

By the end of this seminar, participants should be able to:

1. Describe the characteristics of patients who seek web-based medication abortion services versus in-clinic services

2. Understand the factors related to increased demand for web-based medication abortion services

To join a seminar or to be added to the Research Seminar mailing list, please e-mail Azelea Sayavong: azeleagn@uw.edu.